Drug Shortage Report for ACETYLCYSTEINE SOLUTION
Report ID | 73185 |
Drug Identification Number | 02243098 |
Brand name | ACETYLCYSTEINE SOLUTION |
Common or Proper name | ACETYLCYSTEINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCYSTEINE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INTRAVENOUS ORAL |
Packaging size | 10 |
ATC code | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-10-15 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2022-06-17 |
Shortage status | Resolved |
Updated date | 2022-06-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-06-18 | English | Compare |
v4 | 2022-06-17 | French | Compare |
v3 | 2022-06-17 | English | Compare |
v2 | 2019-01-21 | French | Compare |
v1 | 2019-01-21 | English | Compare |
Showing 1 to 5 of 5